These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6800465)

  • 21. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
    Baumgartner A; Jacot N; Moser G; Krähenbühl B
    Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of thromboembolism with low-molecular weight heparin in pregnancy].
    Harenberg J; Leber G; Zimmermann R; Schmidt W
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):15-8. PubMed ID: 3569823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-surgical deep vein thrombosis prevention: evaluation of the risk/benefit ratio of fractionated and unfractionated heparin.
    Garcea D; Martuzzi F; Santelmo N; Savoia M; Casertano MG; Furno A; Ruggeri V
    Curr Med Res Opin; 1992; 12(9):572-83. PubMed ID: 1316258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
    Br J Surg; 1997 Aug; 84(8):1099-103. PubMed ID: 9278651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
    JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis.
    Schmitz-Huebner U; Bünte H; Freise G; Reers B; Rüschemeyer C; Scherer R; Schulte H; van de Loo J
    Klin Wochenschr; 1984 Apr; 62(8):349-53. PubMed ID: 6374278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of postoperative deep vein thrombosis: selective use of low-dose heparin in high-risk patients.
    Crandon AJ; Peel KR; Anderson JA; Thompson V; McNicol GP
    Br Med J; 1980 Aug; 281(6236):345-7. PubMed ID: 7427272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
    Caen JP
    Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low molecular weight heparins].
    Kher A; Bara L; Samama M
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
    Onarheim H; Lund T; Heimdal A; Arnesjø B
    Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.
    Dechavanne M; Ville D; Berruyer M; Trepo F; Dalery F; Clermont N; Lerat JL; Moyen B; Fischer LP; Kher A
    Haemostasis; 1989; 19(1):5-12. PubMed ID: 2537787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.
    Levine MN; Planes A; Hirsh J; Goodyear M; Vochelle N; Gent M
    Thromb Haemost; 1989 Nov; 62(3):940-4. PubMed ID: 2556813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative deep vein thrombosis of the lower limb and prophylactic value of heparin evaluated by phlebography.
    Kiil J; Møoller JC
    Acta Radiol Diagn (Stockh); 1979; 20(3):507-12. PubMed ID: 393078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of deep-vein thrombosis following total hip replacement surgery with enoxaparin versus unfractionated heparin: a pharmacoeconomic evaluation.
    Menzin J; Richner R; Huse D; Colditz GA; Oster G
    Ann Pharmacother; 1994 Feb; 28(2):271-5. PubMed ID: 8173149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged activated partial thromboplastin time in thromboprophylaxis with unfractionated heparin in patients undergoing cesarean section.
    Matsubara S; Usui R; Ohkuchi A; Okuno S; Izumi A; Watanabe T; Seo N; Suzuki M
    J Obstet Gynaecol Res; 2010 Feb; 36(1):58-63. PubMed ID: 20178528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications.
    Bergqvist D; Burmark US; Frisell J; Hallböök T; Lindblad B; Risberg B; Törngren S; Wallin G
    Haemostasis; 1986; 16 Suppl 2():11-8. PubMed ID: 3744131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.